Perioperative management of direct oral anticoagulants in patients undergoing radical prostatectomy: results of a prospective assessment

Abstract

Introduction and objectives

In the perioperative setting, temporary interruption of direct oral anticoagulants (DOACs) is recommended. However, the safety of these recommendations is based on non-urological surgical experiences. Our objective was to verify the safety of these recommendations in patients undergoing radical prostatectomy (RP).

Materials and methods

Patients regularly receiving a DOAC and scheduled for RP at our institution were prospectively assessed. DOAC intake was usually stopped 48 h before surgery without any preoperative bridging therapy. Postoperatively, patients received risk-adapted low-molecular weight heparin (LMWH). On the third day after unremarkable RP, DOAC intake was restarted and the administration of LMWH was stopped. We assessed perioperative outcomes and 30-day morbidity.

Results

Thirty-two consecutive patients receiving DOAC underwent RP at our institution between 12/2017 and 07/2018. Time of surgery (median, 177 min) and intraoperative blood loss (median, 500 mL) were unremarkable. DOACs were restarted on the third postoperative day in 30 patients (94%). No patient had a significant hemoglobin level reduction after DOAC restart. Overall, 28% of patients experienced complications within 30 days after surgery. Most of which were minor (Clavien ≤ 2), three patients (9%), however, had Clavien ≥ 3 complications.

Conclusion

Our report is the first to prospectively assess current guideline recommendations regarding DOAC restarting after major urological surgery. RP can safely be performed, if DOACs are correctly paused before surgery. Moreover, in case of an uneventful postoperative clinical course, DOACs can be safely restarted on the third postoperative day. A 9% Clavien ≥ 3 30-day morbidity warrants attention and should be further explored in future studies.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Mottet N, Bellmunt J, Bolla M, Briers E, Cumberbatch MG, De Santis M et al (2017) EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol 71(4):618–629

    Article  Google Scholar 

  2. 2.

    Rose DK, Bar B (2018) Direct oral anticoagulant agents: pharmacologic profile, indications, coagulation monitoring, and reversal agents. J Stroke Cerebrovasc Dis 27(8):2049–2058

    Article  Google Scholar 

  3. 3.

    Kaatz S, Mahan CE, Nakhle A, Gunasekaran K, Ali M, Lavender R et al (2017) Management of elective surgery and emergent bleeding with direct oral anticoagulants. Curr Cardiol Rep 19(12):124

    Article  Google Scholar 

  4. 4.

    Kristensen SD, Knuuti J, Saraste A, Anker S, Botker HE, De Hert S et al (2014) 2014 ESC/ESA guidelines on non-cardiac surgery: cardiovascular assessment andmanagement. Kardiol Pol 72(11):857–918

    Article  Google Scholar 

  5. 5.

    Walz J, Epstein JI, Ganzer R, Graefen M, Guazzoni G, Kaouk J et al (2016) A critical analysis of the current knowledge of surgical anatomy of the prostate related to optimisation of cancer control and preservation of continence and erection in candidates for radical prostatectomy: an update. Eur Urol 70(2):301–311

    Article  Google Scholar 

  6. 6.

    Saily VM, Petas A, Joutsi-Korhonen L, Taari K, Lassila R, Rannikko AS (2014) Dabigatran for thromboprophylaxis after robotic assisted laparoscopic prostatectomy: retrospective analysis of safety profile and effect on blood coagulation. Scand J Urol 48(2):153–159

    Article  Google Scholar 

  7. 7.

    Schlomm T, Heinzer H, Steuber T, Salomon G, Engel O, Michl U et al (2011) Full functional-length urethral sphincter preservation during radical prostatectomy. Eur Urol 60(2):320–329

    Article  Google Scholar 

  8. 8.

    Schlomm T, Tennstedt P, Huxhold C, Steuber T, Salomon G, Michl U et al (2012) Neurovascular structure-adjacent frozen-section examination (NeuroSAFE) increases nerve-sparing frequency and reduces positive surgical margins in open and robot-assisted laparoscopic radical prostatectomy: experience after 11,069 consecutive patients. Eur Urol 62(2):333–340

    Article  Google Scholar 

  9. 9.

    Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213

    Article  Google Scholar 

  10. 10.

    Pompe RS, Beyer B, Haese A, Preisser F, Michl U, Steuber T et al (2018) Postoperative complications of contemporary open and robot-assisted laparoscopic radical prostatectomy using standardised reporting systems. BJU Int 122(5):801–807

    CAS  Article  Google Scholar 

  11. 11.

    Violette PD, Cartwright R, Briel M, Tikkinen KA, Guyatt GH (2016) Guideline of guidelines: thromboprophylaxis for urological surgery. BJU Int 118(3):351–358

    Article  Google Scholar 

Download references

Funding

Hendrik Isbarn has received lecture fees from Daiichi Sankyo. Florian Langer has received lecture fees, honoraria for advisory boards, travel and/or research support from Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Daiichi Sankyo, Pfizer and Sanofi.

Author information

Affiliations

Authors

Contributions

AB project development, data collection, manuscript writing. JS project development, data collection, manuscript writing. FL project development, data collection, manuscript writing. HH data collection, manuscript writing. LB data collection, manuscript writing. DT data collection, manuscript writing. UM data collection, manuscript writing. AS data collection, manuscript writing. TS data collection, manuscript writing. VV data collection, manuscript writing. GS data collection, manuscript writing. AH data collection, manuscript writing. HH data collection, manuscript writing. MG data collection, manuscript writing. HI project development, data collection, manuscript writing, data analysis

Corresponding author

Correspondence to Hendrik Isbarn.

Ethics declarations

Research involving human participants and/or animals

Human participants: yes. Animals: no.

Informed consent

Provided by all patients.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Beckmann, A., Spalteholz, J., Langer, F. et al. Perioperative management of direct oral anticoagulants in patients undergoing radical prostatectomy: results of a prospective assessment. World J Urol 37, 2657–2662 (2019). https://doi.org/10.1007/s00345-019-02668-z

Download citation

Keywords

  • Radical prostatectomy
  • DOAC
  • Prostate cancer